SELECTIVE TARGETED ANTIBODY REPLACEMENTS

1 total filings · 0 classes · Active since Jan 2026

SELECTIVE TARGETED ANTIBODY REPLACEMENTS holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals) with 1 filings. The WikiTrademarks Expansion Score is 24/100, low — the brand is focused on defending its existing categories rather than expanding.

USPTO data refreshed June 15, 2026

Own this brand? Claim the profile to add your logo, story, and website.

Sign in to claim

How is SELECTIVE TARGETED ANTIBODY REPLACEMENTS filing trademarks, and where is the portfolio expanding?

Filing Velocity (24 Months)

Jul 2024 Jun 2026

Filing Activity by NICE Class

Nice Class Distribution

Activity Timeline

No activity recorded yet.

Recent Filings

Serial No. Mark Filing Date Status Classes Owner
99602322 SELECTIVE TARGETED ANTIBODY REPLACEMENTS Jan 19, 2026 Registered 005 Pharmaceuticals Firebird Diagnotics
See how ChatGPT talks about SELECTIVE TARGETED ANTIBODY REPLACEMENTS Beta

Weekly visibility reports showing how ChatGPT mentions SELECTIVE TARGETED ANTIBODY REPLACEMENTS, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.

Join waitlist →

FAQ: SELECTIVE TARGETED ANTIBODY REPLACEMENTS trademark portfolio

What trademarks does SELECTIVE TARGETED ANTIBODY REPLACEMENTS hold?

SELECTIVE TARGETED ANTIBODY REPLACEMENTS holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals). The most recent filings are registered to Firebird Diagnotics.

How many trademarks does SELECTIVE TARGETED ANTIBODY REPLACEMENTS have at the USPTO?

WikiTrademarks tracks 1 USPTO trademark filings attributed to SELECTIVE TARGETED ANTIBODY REPLACEMENTS. The brand has been actively filing since January 2026. The count updates daily as new filings are indexed from the USPTO bulk data feed.

In which NICE classes does SELECTIVE TARGETED ANTIBODY REPLACEMENTS file most often?

SELECTIVE TARGETED ANTIBODY REPLACEMENTS's most active class is NICE Class 5 (Pharmaceuticals), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.

Who owns the SELECTIVE TARGETED ANTIBODY REPLACEMENTS trademark?

The most recent filings under the SELECTIVE TARGETED ANTIBODY REPLACEMENTS mark are registered to Firebird Diagnotics. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.

Is SELECTIVE TARGETED ANTIBODY REPLACEMENTS expanding into new categories?

The current WikiTrademarks Expansion Score for SELECTIVE TARGETED ANTIBODY REPLACEMENTS is 24 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.

How can I track new SELECTIVE TARGETED ANTIBODY REPLACEMENTS trademark filings?

Click the Watch Brand button at the top of this page to add SELECTIVE TARGETED ANTIBODY REPLACEMENTS to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.

More on this portfolio: Compare SELECTIVE TARGETED ANTIBODY REPLACEMENTS to another owner · Browse all NICE classes · Most valuable brands

Community notes

0 notes
Sign in to add a note

Share what you know about SELECTIVE TARGETED ANTIBODY REPLACEMENTS and help the next person researching it.

No notes yet. Be the first to add what you know about SELECTIVE TARGETED ANTIBODY REPLACEMENTS.